Federico Vozella

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera.

NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera.

Journal: Annals of hematology
Published: February 18, 2026

Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.

Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.

Journal: Hematological oncology
Published: October 18, 2025

Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort.

Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort.

Journal: Blood advances
Published: October 15, 2025

Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort.

Journal: Blood advances
Published: October 15, 2025

Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice.

Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice.

Journal: Haematologica
Published: March 20, 2025

Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature review.

Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature review.

Journal: World journal of hepatology
Published: February 20, 2025

Monoclonal antibodies in multiple myeloma.

Monoclonal antibodies in multiple myeloma.

Journal: Panminerva medica
Published: September 21, 2020

Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?

Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?

Journal: Journal of bone oncology
Published: March 31, 2020

Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group.

Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group.

Journal: Annals of hematology
Published: March 22, 2020

PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count.

PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count.

Journal: Journal of thrombosis and thrombolysis
Published: January 26, 2020

The Anti-CD38 Antibody Therapy in Multiple Myeloma.

The Anti-CD38 Antibody Therapy in Multiple Myeloma.

Journal: Cells
Published: November 04, 2019

Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib.

Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib.

Journal: Oncology research and treatment
Published: March 25, 2019
Showing 1-12 of 25

Last Updated: 09/26/2026